Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
GLP-1 / GIP (active ingredient tirzepatide) medication has been FDA approved under the name Zepbound* for weight loss
TB-500 makes more sense when: The injury is deep or hard to reach with an injection (spine, deep hip, cardiac tissue) You're dealing with multiple injuries at the same time Recovery involves systemic inflammation rather than something localized BPC-157 makes more sense when: The injury is easy to inject near (knee, shoulder, elbow, ankle) Gut healing is the main goal, since BPC-157's strongest documented effects are in the GI tract You're targeting a neurological issue through a localized administration route Neither peptide has human RCT data for musculoskeletal use yet
Root Cause: Many payers require the NDC along with the HCPCS or CPT code to process claims for injectable medications
International variation Peptide regulations vary by country
- Increased Flexibility and Mobility: TB-500 is known to enhance flexibility and mobility by supporting the health of muscles and connective tissues
This is not a technical footnote
